TIDMDPH

RNS Number : 2548O

Dechra Pharmaceuticals PLC

06 October 2021

6 October 2021

Dechra(R) Pharmaceuticals PLC

(Dechra or the Company)

Notification and public disclosure of transactions by

persons discharging managerial responsibilities (PDMRs)

Dechra Pharmaceuticals PLC announces that on 5 October 2021, Paul Sandland, Executive Director and PDMR exercised market value options over ordinary shares of 1p each in the Company. The options were granted under the Dechra Pharmaceuticals 2017 Long Term Incentive Plan as detailed below before Paul Sandland's appointment as an Executive Director. The exercise of the options was subject to the achievement of performance conditions which were satisfied to the extent that the options vested at 100%. Paul Sandland sold 3,960 of the shares acquired to fund the exercise prices and tax liabilities arising in connection with the exercises of the unapproved share options, and retained the remaining 2,040 shares.

 
 Date of       Scheme       Number of   Option Price  Number of shares   Sale 
  Grant                      options                   sold               Price 
                             exercised 
 2 March       Approved     550         GBP25.06      Nil                N/A 
  2018 
 2 March 
  2018         Unapproved   2,450       GBP25.06      1,830              GBP48.285 
 26 October 
  2018         Unapproved   3,000       GBP21.66      2,130              GBP48.285 
 

Paul Sandland's total beneficial holding following these transactions is 9,651 ordinary shares which represents 0.009% of the total issued share capital.

The Notification of Dealing Forms set out below are provided in accordance with the requirements of the UK Market Abuse Regulation.

Notification of Dealing Forms

 
 1.   Details of the Person Discharging Managerial Responsibility 
       ("PDMR")/person closely associated with them ("PCA") 
 a)   Name                                  Paul Sandland 
     ------------------------------------  ------------------------------------------- 
 2.   Reason for the notification 
     --------------------------------------------------------------------------------- 
 a)   Position/status                       Director/Chief Financial Officer 
     ------------------------------------  ------------------------------------------- 
 b)   Initial notification/                 Initial Notification 
       amendment 
     ------------------------------------  ------------------------------------------- 
 3.   Details of the Issuer 
     --------------------------------------------------------------------------------- 
 a)   Name                                  Dechra Pharmaceuticals PLC 
     ------------------------------------  ------------------------------------------- 
 b)   LEI code                              213800J4UVB5OWG8VX82 
     ------------------------------------  ------------------------------------------- 
 4.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of 
       transaction; (iii) each date; and (iv) each place 
       where transactions have been conducted 
     --------------------------------------------------------------------------------- 
 a)   Description of                        Ordinary Shares of 1 pence each 
       the financial 
       instrument 
                                             ISIN: GB0009633180 
       Identification 
       code 
     ------------------------------------  ------------------------------------------- 
 b)   Nature of the                         Exercise of options under the Company's 
       transaction                           2017 Long Term Incentive Plan (Approved 
                                             Options) 
     ------------------------------------  ------------------------------------------- 
 c)   Price(s) and volumes(s)               Price(s)               Volume(s) 
                                             GBP25.06               550 
     ------------------------------------  ---------------------  -------------------- 
 d)        Aggregated information 
             *    Aggregate volume 
                                              550 
                                              GBP25.06 
             *    Price                       GBP13,783.00 
 
 
             *    Total 
     ------------------------------------  ------------------------------------------- 
 e)   Date of the transaction               2021.10.05 
     ------------------------------------  ------------------------------------------- 
 f)   Place of the transaction              Outside a trading venue 
     ------------------------------------  ------------------------------------------- 
 
 
 1.   Details of the Person Discharging Managerial Responsibility 
       ("PDMR")/person closely associated with them ("PCA") 
 a)   Name                                  Paul Sandland 
     ------------------------------------  --------------------------------------------- 
 2.   Reason for the notification 
     ----------------------------------------------------------------------------------- 
 a)   Position/status                       Director/Chief Financial Officer 
     ------------------------------------  --------------------------------------------- 
 b)   Initial notification/                 Initial Notification 
       amendment 
     ------------------------------------  --------------------------------------------- 
 3.   Details of the Issuer 
     ----------------------------------------------------------------------------------- 
 a)   Name                                  Dechra Pharmaceuticals PLC 
     ------------------------------------  --------------------------------------------- 
 b)   LEI code                              213800J4UVB5OWG8VX82 
     ------------------------------------  --------------------------------------------- 
 4.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of 
       transaction; (iii) each date; and (iv) each place 
       where transactions have been conducted 
     ----------------------------------------------------------------------------------- 
 a)   Description of                        Ordinary Shares of 1 pence each 
       the financial 
       instrument 
                                             ISIN: GB0009633180 
       Identification 
       code 
     ------------------------------------  --------------------------------------------- 
 b)   Nature of the                         Exercise of options under the Company's 
       transaction                           2017 Long Term Incentive Plan (Unapproved 
                                             Options) 
     ------------------------------------  --------------------------------------------- 
 c)   Price(s) and volumes(s)               Price(s)                Volume(s) 
                                             GBP25.06                2,450 
                                             GBP21.66                3,000 
     ------------------------------------  ----------------------  --------------------- 
 d)        Aggregated information 
             *    Aggregate volume 
                                              5,450 
                                              GBP23.188 
             *    Price 
                                              GBP126,377.00 
 
             *    Total 
     ------------------------------------  --------------------------------------------- 
 e)   Date of the transaction               2021.10.05 
     ------------------------------------  --------------------------------------------- 
 f)   Place of the transaction              Outside a trading venue 
     ------------------------------------  --------------------------------------------- 
 
 
 1.   Details of the Person Discharging Managerial Responsibility 
       ("PDMR")/person closely associated with them ("PCA") 
 a)   Name                                 Paul Sandland 
     -----------------------------------  ---------------------------------------------- 
 2.   Reason for the notification 
     ----------------------------------------------------------------------------------- 
 a)   Position/status                      Director/Chief Financial Officer 
     -----------------------------------  ---------------------------------------------- 
 b)   Initial notification/                Initial Notification 
       amendment 
     -----------------------------------  ---------------------------------------------- 
 3.   Details of the Issuer 
     ----------------------------------------------------------------------------------- 
 a)   Name                                 Dechra Pharmaceuticals PLC 
     -----------------------------------  ---------------------------------------------- 
 b)   LEI code                             213800J4UVB5OWG8VX82 
     -----------------------------------  ---------------------------------------------- 
 4.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of 
       transaction; (iii) each date; and (iv) each place 
       where transactions have been conducted 
     ----------------------------------------------------------------------------------- 
 a)   Description of                       Ordinary Shares of 1 pence each 
       the financial 
       instrument 
                                            ISIN: GB0009633180 
       Identification 
       code 
     -----------------------------------  ---------------------------------------------- 
 b)   Nature of the                        Sale of shares obtained under the Company's 
       transaction                          2017 Long Term Incentive Plan (Unapproved 
                                            Options) 
     -----------------------------------  ---------------------------------------------- 
 c)   Price(s) and volumes(s)              Price(s)                   Volume(s) 
                                            GBP 48.285                 3,960 
     -----------------------------------  -------------------------  ------------------- 
 d)        Aggregated information 
             *    Aggregate volume           3,960 
 
                                             GBP 48.285 
             *    Price                      GBP191,208.60 
 
 
             *    Total 
     -----------------------------------  ---------------------------------------------- 
 e)   Date of the transaction              2021.10.05 
     -----------------------------------  ---------------------------------------------- 
 f)   Place of the transaction             London Stock Exchange 
     -----------------------------------  ---------------------------------------------- 
 

For further information, please contact:

Melanie Hall, Company Secretary

Telephone number: 01606 814730

About Dechra

Dechra is a global specialist veterinary pharmaceuticals and related products business. Our expertise is in the development, manufacture, and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products. For more information please visit: www.dechra.com

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHBSBDGIXGDGBL

(END) Dow Jones Newswires

October 06, 2021 10:40 ET (14:40 GMT)

Grafico Azioni Dechra Pharmaceuticals (LSE:DPH)
Storico
Da Nov 2021 a Dic 2021 Clicca qui per i Grafici di Dechra Pharmaceuticals
Grafico Azioni Dechra Pharmaceuticals (LSE:DPH)
Storico
Da Dic 2020 a Dic 2021 Clicca qui per i Grafici di Dechra Pharmaceuticals